相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A Hydrogen Peroxide-Inactivated Virus Vaccine Elicits Humoral and Cellular Immunity and Protects against Lethal West Nile Virus Infection in Aged Mice
Amelia K. Pinto et al.
JOURNAL OF VIROLOGY (2013)
West Nile Virus Infection in Belgian Traveler Returning from Greece
Lieselotte Cnops et al.
EMERGING INFECTIOUS DISEASES (2013)
Circulation of West Nile virus lineage 1 and 2 during an outbreak in Italy
F. Magurano et al.
CLINICAL MICROBIOLOGY AND INFECTION (2012)
Phase II, dose ranging study of the safety and immunogenicity of single dose West Nile vaccine in healthy adults ≥50 years of age
Gustavo H. Dayan et al.
VACCINE (2012)
Characterization of Virulent West Nile Virus Kunjin Strain, Australia, 2011
Melinda J. Frost et al.
EMERGING INFECTIOUS DISEASES (2012)
Recent progress in West Nile virus diagnosis and vaccination
Marina De Filette et al.
VETERINARY RESEARCH (2012)
Detection of West Nile virus lineage 2 in mosquitoes during a human outbreak in Greece
A. Papa et al.
CLINICAL MICROBIOLOGY AND INFECTION (2011)
Vaccines and immunotherapeutics for the prevention and treatment of infections with West Nile virus
David W. C. Beasley
IMMUNOTHERAPY (2011)
Phase II, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Investigate the Immunogenicity and Safety of a West Nile Virus Vaccine in Healthy Adults
Rex Biedenbender et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
A West Nile Virus DNA Vaccine Utilizing a Modified Promoter Induces Neutralizing Antibody in Younger and Older Healthy Adults in a Phase I Clinical Trial
Julie E. Ledgerwood et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Protection provided by a recombinant ALVAC®-WNV vaccine expressing the prM/E genes of a lineage 1 strain of WNV against a virulent challenge with a lineage 2 strain
J. M. Minke et al.
VACCINE (2011)
Efficacy of Three Vaccines in Protecting Western Scrub-Jays (Aphelocoma californica) from Experimental Infection with West Nile Virus: Implications for Vaccination of Island Scrub-Jays (Aphelocoma insularis)
Sarah S. Wheeler et al.
VECTOR-BORNE AND ZOONOTIC DISEASES (2011)
Detection and molecular analysis of West Nile virus infections in birds of prey in the eastern part of Austria in 2008 and 2009
Eveline Wodak et al.
VETERINARY MICROBIOLOGY (2011)
Outbreak of West Nile Virus Infection in Greece, 2010
Kostas Danis et al.
EMERGING INFECTIOUS DISEASES (2011)
Phylogenetic Analysis of West Nile Virus Isolates, Italy, 2008-2009
Giada Rossini et al.
EMERGING INFECTIOUS DISEASES (2011)
Recombinant vesicular stomatitis virus-based west Nile vaccine elicits strong humoral and cellular immune responses and protects mice against lethal challenge with the virulent west Nile virus strain LSU-AR01
Arun V. Iyer et al.
VACCINE (2009)
Complete genome analysis and virulence characteristics of the Louisiana West Nile virus strain LSU-AR01
Arun V. Iyer et al.
VIRUS GENES (2009)
The Zoonotic Flaviviruses of Southern, South-Eastern and Eastern Asia, and Australasia: The Potential for Emergent Viruses
J. S. Mackenzie et al.
ZOONOSES AND PUBLIC HEALTH (2009)
Lineage 2 West Nile Virus as Cause of Fatal Neurologic Disease in Horses, South Africa
Marietjie Venter et al.
EMERGING INFECTIOUS DISEASES (2009)
Single-round infectious particles enhance immunogenicity of a DNA vaccine against West Nile virus
David C. Chang et al.
NATURE BIOTECHNOLOGY (2008)
Epidemiology of West Nile infection in Volgograd, Russia, in relation to climate change and mosquito (Diptera: Culicidae) bionomics
Alexander E. Platonov et al.
PARASITOLOGY RESEARCH (2008)
Immunization with West Nile virus envelope domain III protects mice against lethal infection with homologous and heterologous virus
Byron E. Martina et al.
VACCINE (2008)
A West Nile virus DNA vaccine induces neutralizing antibody in healthy adults during a phase 1 clinical trial
Julie E. Martin et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Antibodies targeting linear determinants of the envelope protein protect mice against West Nile virus
Michel Ledizet et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Safety and efficacy in geese of a PER.C6-based inactivated West Nile virus vaccine
Itzchak Samina et al.
VACCINE (2007)
The continuing spread of West Nile virus in the Western Hemisphere
Duane J. Gubler
CLINICAL INFECTIOUS DISEASES (2007)
Mosquitoes inoculate high doses of west nile virus as they probe and feed on live hosts
Linda M. Styer et al.
PLOS PATHOGENS (2007)
West Nile virus: Recent trends in diagnosis and vaccine development
G. Dauphin et al.
VACCINE (2007)
Dengue vaccines approach the finish line
Robert Edelman
CLINICAL INFECTIOUS DISEASES (2007)
The long-term outcomes of human West Nile virus infection
James J. Sejvar
CLINICAL INFECTIOUS DISEASES (2007)
The molecular basis of antibody-mediated neutralization of West Nile virus
Theodore Oliphant et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2007)
A West Nile virus recombinant protein vaccine that coactivates innate and adaptive immunity
William F. McDonald et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Efficacy and durability of a recombinant subunit West Nile vaccine candidate in protecting hamsters from West Nile encephalitis
Douglas M. Watts et al.
VACCINE (2007)
Live-attenuated recombinant equine herpesvirus type 1 (EHV-1) induces a neutralizing antibody response against West Nile virus (WNV)
Cristina T. Rosas et al.
VIRUS RESEARCH (2007)
The stoichiometry of antibody-mediated neutralization and enhancement of west nile virus infection
Theodore C. Pierson et al.
CELL HOST & MICROBE (2007)
West Nile virus isolates from India: evidence for a distinct genetic lineage
Vijay P. Bondre et al.
JOURNAL OF GENERAL VIROLOGY (2007)
Immunization of flavivirus West Nile recombinant envelope domain III protein induced specific immune response and protection against West Nile virus infection
Jang-Hann J. Chu et al.
JOURNAL OF IMMUNOLOGY (2007)
Preparation and immunogenic properties of a recombinant West Nile subunit vaccine
Michael M. Lieberman et al.
VACCINE (2007)
Baboon model for West Nile Virus infection and vaccine evaluation
Roman F. Wolf et al.
VIROLOGY (2006)
Chimeric West Nile/dengue virus vaccine candidate: Preclinical evaluation in mice, geese and monkeys for safety and immunogenicity
Alexander G. Pletnev et al.
VACCINE (2006)
Manifestations of West Nile neuroinvasive disease
James J. Sejvar et al.
REVIEWS IN MEDICAL VIROLOGY (2006)
West Nile Virus in the United States (1999-2005)
Reid Gerhardt
JOURNAL OF THE AMERICAN ANIMAL HOSPITAL ASSOCIATION (2006)
West Nile virus meningoencephalitis
RL DeBiasi et al.
NATURE CLINICAL PRACTICE NEUROLOGY (2006)
A live, attenuated recombinant West Nile virus vaccine
TP Monath et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
A single immunization with a minute dose of a lentiviral vector-based vaccine is highly effective at eliciting protective humoral immunity against West Nile virus
Maria Candela Iglesias et al.
JOURNAL OF GENE MEDICINE (2006)
Cryo-EM reconstruction of dengue virus in complex with the carbohydrate recognition domain of DC-SIGN
E Pokidysheva et al.
CELL (2006)
Quantifying the specific binding between West Nile virus envelope domain III protein and the cellular receptor αVβ3 integrin
JWM Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
West Nile virus neuroinvasive disease
Larry E. Davis et al.
ANNALS OF NEUROLOGY (2006)
An inactivated West Nile virus vaccine for domestic geese-efficacy study and a summary of 4 years of field application
I Samina et al.
VACCINE (2005)
Structural basis of West Nile virus neutralization by a therapeutic antibody
GE Nybakken et al.
NATURE (2005)
Recovery and prognosticators of paralysis in West Nile virus infection
NJY Cao et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2005)
Epidemiology and transmission dynamics of West Nile Virus disease
EB Hayes et al.
EMERGING INFECTIOUS DISEASES (2005)
Virology, pathology, and clinical manifestations of West Nile virus disease
EB Hayes et al.
EMERGING INFECTIOUS DISEASES (2005)
West Nile virus-associated flaccid paralysis
JJ Sejvar et al.
EMERGING INFECTIOUS DISEASES (2005)
Nonviremic transmission of West Nile virus
S Higgs et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
A recombinant envelope protein vaccine against West Nile virus
M Ledizet et al.
VACCINE (2005)
Chimeric dengue 2 PDK-53/West Nile NY99 viruses retain the phenotypic attenuation markers of the candidate PDK-53 vaccine virus and protect mice against lethal challenge with West Nile virus
CYH Huang et al.
JOURNAL OF VIROLOGY (2005)
Recombinant canarypox vectored West Nile virus (WNV) vaccine protects dogs and cats against a mosquito WNV challenge
K Karaca et al.
VACCINE (2005)
Induction of protective antibodies against dengue virus by tetravalent DNA immunization of mice with domain III of the envelope protein
J Mota et al.
VACCINE (2005)
Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus
T Oliphant et al.
NATURE MEDICINE (2005)
Differential expression of domain III neutralizing epitopes on the envelope proteins of West Nile virus strains
L Li et al.
VIROLOGY (2005)
West Nile Virus in Morocco, 2003
I Schuffenecker et al.
EMERGING INFECTIOUS DISEASES (2005)
Novel flavivirus or new lineage of West Nile Virus, central Europe
T Bakonyi et al.
EMERGING INFECTIOUS DISEASES (2005)
Inhibition of West Nile virus entry by using a recombinant domain III from the envelope glycoprotein
JJH Chu et al.
JOURNAL OF GENERAL VIROLOGY (2005)
Live measles vaccine expressing the secreted form of the West Nile virus envelope glycoprotein protects against West Nile virus encephalitis
P Desprès et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
A structural perspective of the Flavivirus life cycle
S Mukhopadhyay et al.
NATURE REVIEWS MICROBIOLOGY (2005)
Skin manifestations of West Nile virus infection
P del Giudice et al.
DERMATOLOGY (2005)
West Nile virus infection: A pediatric perspective
EB Hayes et al.
PEDIATRICS (2004)
Safety and efficacy of chimeric yellow fever-dengue virus tetravalent vaccine formulations in nonhuman primates
F Guirakhoo et al.
JOURNAL OF VIROLOGY (2004)
West Nile Virus: Pathogenesis and therapeutic options
J Gea-Banacloche et al.
ANNALS OF INTERNAL MEDICINE (2004)
Ixodid and argasid tick species and West Nile virus
CH Lawrie et al.
EMERGING INFECTIOUS DISEASES (2004)
West Nile virus: An overview of its spread in europe and the Mediterranean Basin in contrast to its spread in the Americas
HG Zeller et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2004)
West Nile virus encephalitis with myositis and orchitis
RD Smith et al.
HUMAN PATHOLOGY (2004)
Solution structure and antibody binding studies of the envelope protein domain III from the New York strain of West Nile virus
DE Volk et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
West Nile: worldwide current situation in animals and humans
G Dauphin et al.
COMPARATIVE IMMUNOLOGY MICROBIOLOGY AND INFECTIOUS DISEASES (2004)
Long-term prognosis for clinical West Nile virus infection
AL Klee et al.
EMERGING INFECTIOUS DISEASES (2004)
West Nile virus vaccines
RA Hall et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2004)
Induction of sterilizing immunity against west nile virus (WNV), by immunization with WNV-like particles produced in insect cells
M Qiao et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
An attenuated West Nile prototype virus is highly immunogenic and protects against the deadly NY99 strain: a candidate for live WN vaccine development
G Yamshchikov et al.
VIROLOGY (2004)
Outcome of equids with clinical signs of West Nile virus infection and factors associated with death
P Salazar et al.
JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION (2004)
Alligators as West Nile virus amplifiers
K Klenk et al.
EMERGING INFECTIOUS DISEASES (2004)
Experimental infection of cats and dogs with West Nile virus
LE Austgen et al.
EMERGING INFECTIOUS DISEASES (2004)
Assessment of the efficacy of a single dose of a recombinant vaccine against West Nile virus in response to natural challenge with West Nile virus-infected mosquitoes in horses
L Siger et al.
AMERICAN JOURNAL OF VETERINARY RESEARCH (2004)
Chorioretinal involvement in patients with West Nile Virus infection
M Khairallah et al.
OPHTHALMOLOGY (2004)
ChimeriVax-West Nile virus live-attenuated vaccine: Preclinical evaluation of safety, immunogenicity, and efficacy
J Arroyo et al.
JOURNAL OF VIROLOGY (2004)
Evaluation of an outbreak of West Nile virus infection in horses: 569 cases (2002)
LA Schuler et al.
JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION (2004)
Antibody prophylaxis and therapy against West Nile virus infection in wild-type and immunodeficient mice
MJ Engle et al.
JOURNAL OF VIROLOGY (2003)
Partial protective effect of inactivated Japanese encephalitis vaccine on lethal West Nile virus infection in mice
T Takasaki et al.
VACCINE (2003)
Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): Phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen
TP Monath et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
Structure of West Nile virus
S Mukhopadhyay et al.
SCIENCE (2003)
Molecularly engineered live-attenuated chimeric West Nile/dengue virus vaccines protect rhesus monkeys from West Nile virus
AG Pletnev et al.
VIROLOGY (2003)
The role for intravenous immunoglobulin in the treatment of West Nile virus encephalitis
M Haley et al.
CLINICAL INFECTIOUS DISEASES (2003)
DNA vaccine coding for the full-length infectious Kunjin virus RNA protects mice against the New York strain of West Nile virus
RA Hall et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
DNA vaccine for West Nile virus infection in fish crows (Corvus ossifragus)
MJ Turell et al.
EMERGING INFECTIOUS DISEASES (2003)
Clinical spectrum of muscle weakness in human West Nile virus infection
AA Leis et al.
MUSCLE & NERVE (2003)
Neurologic manifestations and outcome of West Nile virus infection
JJ Sejvar et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
West Nile virus infection - A new acute paralytic illness
LE Jeha et al.
NEUROLOGY (2003)
Acute flaccid paralysis and West Nile virus infection
JJ Sejvar et al.
EMERGING INFECTIOUS DISEASES (2003)
Absence of humoral response in flamingos and red-tailed hawks to experimental vaccination with a killed West Nile virus vaccine
KE Nusbaum et al.
AVIAN DISEASES (2003)
The domain III fragment of Japanese encephalitis virus envelope protein: mouse immunogenicity and liposome adjuvanticity
SC Wu et al.
VACCINE (2003)
Asymmetric flaccid paralysis: A neuromuscular presentation of West Nile virus infection
J Li et al.
ANNALS OF NEUROLOGY (2003)
Transmission of West Nile virus from an organ donor to four transplant recipients
M Iwamoto et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Traditional and novel approaches to flavivirus vaccines
KV Pugachev et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY (2003)
West Nile encephalitis presenting as a stroke
EB Kulstad
ANNALS OF EMERGENCY MEDICINE (2003)
A fatal case of West Nile Virus infection in a bone marrow transplant recipient
B Hiatt et al.
CLINICAL INFECTIOUS DISEASES (2003)
Efficacy of killed virus vaccine, live attenuated chimeric virus vaccine, and passive immunization for prevention of West Nile virus encephalitis in hamster model
RB Tesh et al.
EMERGING INFECTIOUS DISEASES (2002)
Identification of neutralizing epitopes within structural domain III of the West Nile virus envelope protein
DWC Beasley et al.
JOURNAL OF VIROLOGY (2002)
Neurological features of West Nile Virus infection during the 2000 outbreak in a regional hospital in Israel
C Klein et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2002)
Viremia and immunogenicity in nonhuman primates of a tetravalent yellow fever-dengue chimeric vaccine: Genetic reconstructions, dose adjustment, and antibody responses against wild-type dengue virus isolates
F Guirakhoo et al.
VIROLOGY (2002)
Complete genome sequences and phylogenetic analysis of West Nile virus strains isolated from the United States, Europe, and the Middle East
RS Lanciotti et al.
VIROLOGY (2002)
Folding and dimerization of tick-borne encephalitis virus envelope proteins prM and E in the endoplasmic reticulum
IC Lorenz et al.
JOURNAL OF VIROLOGY (2002)
Phylogenetic analysis of a human isolate from the 2000 Israel West Nile virus epidemic
T Briese et al.
EMERGING INFECTIOUS DISEASES (2002)
Short report: Absence of protective neutralizng antibodies to West Nile virus in subjects following vaccination with Japanese encephalitis or dengue vaccines
N Kanesa-Thasan et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2002)
Clinical proof of principle for ChimeriVax™:: recombinant live, attenuated vaccines against flavivirus infections
TP Monath et al.
VACCINE (2002)
Immunization with heterologous flaviviruses protective against fatal West Nile encephalitis
RB Tesh et al.
EMERGING INFECTIOUS DISEASES (2002)
Construction, characterization and immunogenicity of recombinant yellow fever 17D-dengue type 2 viruses
PS Caufour et al.
VIRUS RESEARCH (2001)
Immunization of mice against West Nile virus with recombinant envelope protein
T Wang et al.
JOURNAL OF IMMUNOLOGY (2001)
Induction of potent Th1-type immune responses from a novel DNA vaccine for West Nile virus New York isolate (WNV-NY1999)
JS Yang et al.
JOURNAL OF INFECTIOUS DISEASES (2001)
Construction, safety, and immunogenicity in nonhuman primates of a chimeric yellow fever-dengue virus tetravalent vaccine
F Guirakhoo et al.
JOURNAL OF VIROLOGY (2001)
Epidemic West Nile encephalitis, New York, 1999: results of a household-based seroepidemiological survey
F Mostashari et al.
LANCET (2001)
West Nile virus recombinant DNA vaccine protects mouse and horse from virus challenge and expresses in vitro a noninfectious recombinant antigen that can be used in enzyme-linked immunosorbent assays
BS Davis et al.
JOURNAL OF VIROLOGY (2001)
Outbreak of West Nile virus infection, Volgograd Region, Russia, 1999
AE Platonov et al.
EMERGING INFECTIOUS DISEASES (2001)
Guillain-Barre syndrome: An unusual presentation of West Nile virus infection
S Ahmed et al.
NEUROLOGY (2000)
Recombinant chimeric yellow fever-dengue type 2 virus is immunogenic and protective in nonhuman primates
F Guirakhoo et al.
JOURNAL OF VIROLOGY (2000)
Pathology of fatal West Nile virus infections in native and exotic birds during the 1999 outbreak in New York City, New York
KE Steele et al.
VETERINARY PATHOLOGY (2000)
Growth characteristics of the chimeric Japanese encephalitis virus vaccine candidate, ChimeriVax™-JE (YF/JE SAL4-14-2), in Culex tritaeniorhynchus, Aedes albopictus, and Aedes aegypti mosquitoes
TR Bhatt et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2000)
The pathology of human West Nile Virus infection
BA Sampson et al.
HUMAN PATHOLOGY (2000)
The West Nile Virus outbreak of 1999 in New York: The flushing hospital experience
DS Asnis et al.
CLINICAL INFECTIOUS DISEASES (2000)
Chimeric yellow fever virus 17D-Japanese encephalitis virus vaccine: Dose-response effectiveness and extended safety testing in rhesus monkeys
TP Monath et al.
JOURNAL OF VIROLOGY (2000)
A live attenuated West Nile virus strain as a potential veterinary vaccine
S Lustig et al.
VIRAL IMMUNOLOGY (2000)
Chimeric yellow fever/dengue virus as a candidate dengue vaccine: Quantitation of the dengue virus-specific CD8 T-cell response
RG Van Der Most et al.
JOURNAL OF VIROLOGY (2000)
分享论文
